ArriVent Biopharma, Inc.

Current report filing

Certification by an exchange approving securities for listing

Notice of Effectiveness

Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)

Exempt (Private) Offering

Exempt (Private) Offering

Exempt (Private) Offering

LAV Fund VI, L.P.: Major Shareholders

ORBIMED ADVISORS LLC: Major Shareholders

HILLHOUSE INVESTMENT MANAGEMENT, LTD.: Statement of changes in beneficial ownership of securities

GORDON CARL L: Statement of changes in beneficial ownership of securities

HEALY JAMES: Statement of changes in beneficial ownership of securities

ORBIMED ADVISORS LLC: Statement of changes in beneficial ownership of securities

Nolet Chris: Statement of changes in beneficial ownership of securities

Jallal Bahija: Statement of changes in beneficial ownership of securities

Nolet Chris: Initial statement of beneficial ownership of securities

HILLHOUSE INVESTMENT MANAGEMENT, LTD.: Initial statement of beneficial ownership of securities

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Prospectus filed pursuant to Rule 424(b)(4)

A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy